Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de
Werbung:
Studie - Dental Plaque – Pipeline Review, H1 2012
Global Markets Direct
5 / 2012
26 Seiten
| Typ: | Studie |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Dental Plaque — Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Dental Plaque - Pipeline Review, H1 2012', provides an overview of the Dental Plaque therapeutic pipeline. This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. 'Dental Plaque - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Dental Plaque.
- A review of the Dental Plaque products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dental Plaque pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Dental Plaque.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Dental Plaque pipeline depth and focus of Dental Plaque therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Summary
Global Markets Direct’s, 'Dental Plaque - Pipeline Review, H1 2012', provides an overview of the Dental Plaque therapeutic pipeline. This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. 'Dental Plaque - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Dental Plaque.
- A review of the Dental Plaque products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dental Plaque pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Dental Plaque.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Dental Plaque pipeline depth and focus of Dental Plaque therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Dental Plaque Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Dental Plaque 6
Dental Plaque Therapeutics under Development by Companies 8
Dental Plaque Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Early Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
Dental Plaque Therapeutics — Products under Development by Companies 13
Dental Plaque Therapeutics — Products under Investigation by Universities/Institutes 14
Companies Involved in Dental Plaque Therapeutics Development 15
Aphios Corporation 15
Dental Plaque — Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
Asterias - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Chlorhexidine Digluconate - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Green Propolis - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Dental Plaque Therapeutics - Dormant Products 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26
List of Tables
Number of Products Under Development for Dental Plaque, H1 2012 6
Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7
Number of Products under Development by Companies, H1 2012 8
Number of Products under Investigation by Universities/Institutes, H1 2012 9
Comparative Analysis by Mid Clinical Stage Development, H1 2012 10
Comparative Analysis by Early Clinical Stage Development, H1 2012 11
Comparative Analysis by Pre-Clinical Stage Development, H1 2012 12
Products under Development by Companies, H1 2012 13
Products under Investigation by Universities/Institutes, H1 2012 14
Aphios Corporation, H1 2012 15
Assessment by Monotherapy Products, H1 2012 16
Assessment by Stage and Route of Administration, H1 2012 18
Assessment by Stage and Molecule Type, H1 2012 20
Dental Plaque Therapeutics — Dormant Products 24
List of Figures
Number of Products under Development for Dental Plaque, H1 2012 6
Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7
Products under Development by Companies, H1 2012 8
Products under Investigation by Universities/Institutes, H1 2012 9
Mid Clinical Stage Products, H1 2012 10
Early Clinical Stage Products, H1 2012 11
Pre-Clinical Stage Products, H1 2012 12
Assessment by Monotherapy Products, H1 2012 16
Assessment by Route of Administration, H1 2012 17
Assessment by Stage and Route of Administration, H1 2012 18
Assessment by Molecule Type, H1 2012 19
Assessment by Stage and Molecule Type, H1 2012 20
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Dental Plaque Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Dental Plaque 6
Dental Plaque Therapeutics under Development by Companies 8
Dental Plaque Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Early Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
Dental Plaque Therapeutics — Products under Development by Companies 13
Dental Plaque Therapeutics — Products under Investigation by Universities/Institutes 14
Companies Involved in Dental Plaque Therapeutics Development 15
Aphios Corporation 15
Dental Plaque — Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
Asterias - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Chlorhexidine Digluconate - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Green Propolis - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Dental Plaque Therapeutics - Dormant Products 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26
List of Tables
Number of Products Under Development for Dental Plaque, H1 2012 6
Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7
Number of Products under Development by Companies, H1 2012 8
Number of Products under Investigation by Universities/Institutes, H1 2012 9
Comparative Analysis by Mid Clinical Stage Development, H1 2012 10
Comparative Analysis by Early Clinical Stage Development, H1 2012 11
Comparative Analysis by Pre-Clinical Stage Development, H1 2012 12
Products under Development by Companies, H1 2012 13
Products under Investigation by Universities/Institutes, H1 2012 14
Aphios Corporation, H1 2012 15
Assessment by Monotherapy Products, H1 2012 16
Assessment by Stage and Route of Administration, H1 2012 18
Assessment by Stage and Molecule Type, H1 2012 20
Dental Plaque Therapeutics — Dormant Products 24
List of Figures
Number of Products under Development for Dental Plaque, H1 2012 6
Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7
Products under Development by Companies, H1 2012 8
Products under Investigation by Universities/Institutes, H1 2012 9
Mid Clinical Stage Products, H1 2012 10
Early Clinical Stage Products, H1 2012 11
Pre-Clinical Stage Products, H1 2012 12
Assessment by Monotherapy Products, H1 2012 16
Assessment by Route of Administration, H1 2012 17
Assessment by Stage and Route of Administration, H1 2012 18
Assessment by Molecule Type, H1 2012 19
Assessment by Stage and Molecule Type, H1 2012 20
- Adult Mouth Care in Argentina
- Adult Mouth Care in Canada
- Adult Mouth Care in Denmark
- Adult Mouth Care in Guatemala
- Adult Mouth Care in Hong Kong, China
- Adult Mouth Care in Norway
- Adult Mouth Care in Tunisia
- Adult Mouth Care in Turkey
- Dental Caries – Pipeline Review, H1 2013
- Krankenhäuser, medizinische und zahnmedizinische Dienstleistungen in Mexiko: ISIC 851
- Adult Mouth Care in Algeria
- Adult Mouth Care in Azerbaijan
- Adult Mouth Care in Chile
- Adult Mouth Care in China
- Adult Mouth Care in Finland
- Adult Mouth Care in Greece
- Adult Mouth Care in Kazakhstan
- Adult Mouth Care in Latvia
- Adult Mouth Care in Lithuania
- Adult Mouth Care in Poland
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Hinweise: **The report can be shared by users within one office (one geographical location)
***Across Geographical locations (by the purchasing company only)
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:



